Table 5 Parameters include baseline characteristics, microbiological identification, management and impact of mediastinitis in surviving and dead patients
From: Post-cardiac surgery fungal mediastinitis: clinical features, pathogens and outcome
Characteristics | Survivors (n = 17) | Non-survivors (n = 23) | p | OR |
|---|---|---|---|---|
Age (yo) | 59 [43–65] | 65 [61–73] | 0.013 | 1.1 [1.02–1.19] |
Male | 14 (82) | 18 (78) | 1 | |
BMI (kg/m2) | 24 [20–26] | 30 [24–32] | 0.028 | 1.21 [1.01–1.47] |
Euroscore II (%) | 12 [4.2–19.4] | 11.7 [4.6–25] | 0.84 | |
SAPS II | 37 [28–40] | 54 [34–61] | 0.012 | 1.07 [1–1.7] |
Admission SOFA | 9 [5–11] | 9 [6–10] | 0.93 | |
Comorbidity n (%) | ||||
Chronic Heart failure | 12 (70) | 17 (74) | 1 | |
COPD | 2 (11) | 5 (21) | 0.68 | |
Chronic kidney disease | 3 (18) | 3 (13) | 0.79 | |
Dialysis | 1 (6) | 0 (0) | 0.42 | |
Diabetes mellitus | 8 (47) | 12 (52) | 0.75 | |
Insulin | 5 (29) | 5 (21) | 0.57 | |
Immunosuppression | 3 (18) | 2 (9) | 0.63 | |
Heart transplanted | 2 (11) | 2 (9) | 1 | |
Recent hospitalization (< 3 months) | 10 (59) | 12 (52) | 0.68 | |
Active Smokers | 4 (24) | 5 (21) | 1 | |
Initial surgery | ||||
Type of surgery, n (%) | ||||
CABG | 3 (18) | 6 (27) | 0.52 | |
Valve replacement | 4 (24) | 5 (22) | 1 | |
Combined (CABG + valve) | 1 (6) | 4 (17) | 0.37 | |
Heart transplantation | 8 (47) | 4 (17) | 0.08 | |
LVAD | 1 (6) | 1 (4) | 1 | |
Other | 2 (12) | 1 (4) | 0.56 | |
Surgery duration (min) | 354 [281–397] | 278 [172–457] | 0.19 | |
CBP duration (min) | 186 [138–211] | 133 [86–185] | 0.19 | |
ACC duration (min) | 107[69–166] | 87 [51–116] | 0.09 | |